Emergencies and Red Flags: When to Seek Help
At a Glance
For a child with juvenile dermatomyositis, severe breathing trouble, blue lips, severe abdominal pain or bleeding, inability to swallow saliva, fainting, or frequent choking require emergency care. Fever, new cough, weakness, ulcers, or swelling need same-day advice from the rheumatology team.
When your child has a rare condition like Juvenile Dermatomyositis (JDM) and is on immunosuppressive medication, it is natural to worry about every new symptom. Always follow the individualized after-hours plan provided by your child’s care team.
Because JDM is a systemic disease (affecting the whole body), there are rare but serious complications that require immediate action [1]. This page helps you distinguish between “routine” JDM symptoms and “red flags” that require an ER visit or a same-day urgent call to your rheumatologist.
When to Go to the Emergency Room (ER)
If you notice any of the following, call emergency services or go to the ER immediately. Mention to the ER staff that your child has Juvenile Dermatomyositis and provide their current list of medications, especially if they are on high-dose steroids (which may require stress dosing).
1. Breathing and Lung Distress
Lung involvement can sometimes progress very quickly, especially in children with the anti-MDA5 antibody [2].
- The Red Flags: Severe or rapidly worsening shortness of breath, rapid breathing, inability to speak normally, or blue-tinted lips/fingernails [3].
- Why it’s an emergency: This may indicate Rapidly Progressive Interstitial Lung Disease (RP-ILD), which can lead to respiratory failure if not treated aggressively in a hospital setting [4][5].
2. Severe Abdominal Pain or Bleeding
Damage to the blood vessels in the gut (GI vasculopathy) is a rare but critical complication, most common in children with the anti-NXP2 antibody [6].
- The Red Flags: Sudden, severe abdominal pain; a hard, “board-like” stomach; or vomit/stools that are bright red or look like coffee grounds (black and tarry) [6][7].
- Why it’s an emergency: These can be signs of a GI perforation (a tear in the bowel) or severe internal bleeding [8].
3. Critical Weakness and Choking
- The Red Flags: Sudden inability to swallow saliva, fainting or altered consciousness, or frequent choking while eating [9].
- Why it’s an emergency: This indicates severe weakness of the airway protection muscles, posing a high risk of aspiration (food or liquid entering the lungs) [9][10].
When to Call Your Rheumatologist (Same Day)
Call your child’s specialist the same day if you notice these “yellow flags.” They require prompt medical advice and assessment, though your doctor will decide if you need the ER.
- New Fever: A fever in an immunosuppressed child can be an infection, or it could be a sign of Macrophage Activation Syndrome (MAS)—a life-threatening “cytokine storm” where the immune system becomes dangerously overactive [11]. Do not wait for a specific test result before seeking care for a fever. Doctors evaluate MAS using the whole clinical picture, including high ferritin, falling blood counts, and abnormal liver and triglyceride tests [1][12].
- New Respiratory Symptoms: A new, persistent dry cough or getting winded easily with exertion (especially in children at risk for ILD) [3].
- New Skin Ulcers: Small sores or “punched-out” holes, especially on the knuckles or fingertips. If they are draining pus, have red streaks, or are extremely painful, they may be infected [13][14].
- Significant Strength Loss: If your child suddenly cannot perform a task they could do yesterday (like standing up or lifting their head), or develops a new weak or nasal voice [15].
- Significant Edema: Widespread swelling in the limbs or face that is new or rapidly worsening [16].
Non-Urgent Symptoms (Discuss at Next Visit)
While frustrating, the following are generally part of the ongoing management of JDM and can be handled during regular business hours. However, do not falsely reassure yourself about new or persistent symptoms. A new fatigue, reduced exercise tolerance, or a rash that worsens after sun exposure can be an early sign of a flare or infection.
- Mild Skin Flaring: Mild increased redness after being in the sun or a warm bath.
- Expected Fatigue: Feeling tired after a long day of school or physical therapy.
- Small “Normal” Fluctuations: Slight changes in strength that don’t prevent daily activities.
- Typical Steroid Side Effects: Increased appetite or “moon face” (rounding of the cheeks) are common side effects of prednisone.
Common questions in this guide
When should I take a child with juvenile dermatomyositis to the ER?
Can a fever be an emergency in a child with JDM?
Which breathing changes are warning signs in juvenile dermatomyositis?
Do anti-MDA5 or anti-NXP2 antibodies increase emergency risks in JDM?
What swallowing or weakness changes need urgent attention in JDM?
How can I tell when abdominal pain may be serious in a child with JDM?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does my child's specific antibody (like anti-MDA5 or anti-NXP2) put them at a higher risk for a specific emergency like lung disease or GI issues?
- 2.What is our 'after-hours' plan if I notice a red flag on a weekend or holiday?
- 3.If my child develops a new fever, which specific blood tests (like ferritin or a CBC) should be ordered to check for MAS?
- 4.Are there specific signs of 'silent' lung or gut issues we should be looking for that might not look like a typical emergency?
- 5.How do I distinguish between a regular stomach ache and the more serious abdominal pain related to JDM?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (16)
- 1
Macrophage activation syndrome in juvenile dermatomyositis: a case report and a comprehensive review of the literature.
Chang Y, Shan X, Ge Y
Pediatric rheumatology online journal 2023; (21(1)):106 doi:10.1186/s12969-023-00893-w.
PMID: 37735702 - 2
[The analysis of clinical phenotypes and autoantibodies in juvenile dermatomyositis].
Li DM, Wang L, Liu MY, et al.
Zhonghua er ke za zhi = Chinese journal of pediatrics 2020; (58(12)):966-972 doi:10.3760/cma.j.cn112140-20200724-00751.
PMID: 33256317 - 3
[Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review].
Hou J, Zhou ZX, Li JG, et al.
Zhonghua er ke za zhi = Chinese journal of pediatrics 2019; (57(12)):928-933 doi:10.3760/cma.j.issn.0578-1310.2019.12.007.
PMID: 31795559 - 4
Successful Treatment of Rapidly Progressive Interstitial Lung Disease in Juvenile Dermatomyositis.
Ciaglia K, Ghawji M, Caraballo M, Sloan E
Pediatrics 2024; (153(3)) doi:10.1542/peds.2023-063268.
PMID: 38361479 - 5
Lung involvement in juvenile idiopathic inflammatory myopathy: A systematic review.
Abu-Rumeileh S, Marrani E, Maniscalco V, et al.
Autoimmunity reviews 2023; (22(10)):103416 doi:10.1016/j.autrev.2023.103416.
PMID: 37611886 - 6
Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature.
Xu Y, Ma X, Zhou Z, et al.
Pediatric rheumatology online journal 2021; (19(1)):2 doi:10.1186/s12969-020-00486-x.
PMID: 33407602 - 7
Relapsing retroperitoenal abscess secondary to juvenile dermatomyositis: Complexity in management.
Jothinathan M, Lau KS, Vanusha D
The Medical journal of Malaysia 2020; (75(2)):178-180.
PMID: 32281605 - 8
Severe Abdominal Manifestations in Juvenile Dermatomyositis.
Besnard C, Gitiaux C, Girard M, et al.
Journal of pediatric gastroenterology and nutrition 2020; (70(2)):247-251 doi:10.1097/MPG.0000000000002575.
PMID: 31978027 - 9
Clinical characteristics and poor predictors of anti-NXP2 antibody-associated Chinese JDM children.
Wang X, Ding Y, Zhou Z, et al.
Pediatric rheumatology online journal 2021; (19(1)):6 doi:10.1186/s12969-020-00492-z.
PMID: 33407621 - 10
Juvenile Dermatomyositis: Advances in Pathogenesis, Assessment, and Management.
Leung AKC, Lam JM, Alobaida S, et al.
Current pediatric reviews 2021; (17(4)):273-287 doi:10.2174/1573396317666210426105045.
PMID: 33902423 - 11
[Clinical and laboratory features of macrophage activation syndrome].
Guo L, Lu MP, Dong GJ, et al.
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2017; (19(2)):188-192.
PMID: 28202118 - 12
Single center clinical analysis of macrophage activation syndrome complicating juvenile rheumatic diseases.
Huang S, Liu Y, Yan W, et al.
Pediatric rheumatology online journal 2024; (22(1)):58 doi:10.1186/s12969-024-00991-3.
PMID: 38783316 - 13
Anti-nuclear matrix protein 2+ juvenile dermatomyositis with severe skin ulcer and infection: A case report and literature review.
Wang YT, Zhang Y, Tang T, et al.
World journal of clinical cases 2022; (10(11)):3579-3586 doi:10.12998/wjcc.v10.i11.3579.
PMID: 35611208 - 14
An Unusual Cause of Necrotising Fasciitis in a Young Male with Juvenile Dermatomyositis.
Asante AA, Nsaful J, Dey D
Case reports in rheumatology 2022; (2022()):8758263 doi:10.1155/2022/8758263.
PMID: 35982709 - 15
How Often are Pediatric Patients with Clinically Amyopathic Dermatomyositis Truly Amyopathic?
Oberle EJ, Bayer ML, Chiu YE, Co DO
Pediatric dermatology 2017; (34(1)):50-57 doi:10.1111/pde.13013.
PMID: 27813167 - 16
Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositis.
Aouizerate J, De Antonio M, Bader-Meunier B, et al.
Rheumatology (Oxford, England) 2018; (57(5)):873-879 doi:10.1093/rheumatology/kex516.
PMID: 29474663
This page is for informational purposes only and does not constitute medical advice or replace your child’s individualized after-hours plan. Contact your child’s care team or emergency services for urgent symptoms.
Get notified when new evidence is published on Juvenile dermatomyositis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.